H.Res. 1337

H.Res. 1337: Recognizing the contributions of academic medicine and observing Academic Medicine Week from June 8 through 12, 2026.

Introduced Kathy Castor (D) HOUSE_RESOLUTION — 119th Congress
Plain English Summary

H.Res. 1337 is a resolution that acknowledges the significant contributions of academic medicine to healthcare and education in the United States. It designates the week of June 8 through June 12 in 2026 as 'Academic Medicine Week' to celebrate and promote the role of academic medical institutions in advancing medical research, education, and patient care.

Positive Media Summary

Media coverage has praised H.Res. 1337 for highlighting the importance of academic medicine in improving healthcare outcomes and fostering innovation. Supporters argue that recognizing Academic Medicine Week will raise awareness about the vital role that academic institutions play in training future healthcare professionals and conducting critical research.

Negative Media Summary

Some critics have expressed concerns that designating a specific week for academic medicine may divert attention and resources away from pressing healthcare issues. They argue that while academic medicine is important, the focus should be on addressing immediate challenges in the healthcare system rather than on ceremonial recognitions.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Health

While there are no direct industry overlaps between the bill's subject matter and the sponsor's top donor industries, there is notable lobbying activity in the healthcare sector related to infection control and pharmaceuticals. Paratek Pharmaceuticals, which has contributed $20,000, and Steelships, LLC, which has contributed $45,000, are involved in this area. The bill recognizes the contributions of academic medicine, potentially benefiting organizations that are lobbying for policies in this domain. Although the risk of conflict is moderate, the presence of significant lobbying dollars suggests that stakeholders may have interests that align with the bill's recognition of academic medicine, which could influence future legislative priorities. Voters should be aware of these connections as they may indicate underlying motivations for supporting the bill.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
STEELSHIPS, LLC CONSCIENCE POINT CONSULTING, INC. $45,000
SAN PASQUAL BAND OF MISSION INDIANS THE FARLEY GROUP, INC. $30,000
PARATEK PHARMACEUTICALS PARATEK PHARMACEUTICALS $20,000
SAN JUAN SOUTHERN PAIUTE TRIBE THE FARLEY GROUP, INC. $15,000
CHURCH ALLIANCE K&L GATES, LLP $10,000
GIFDA RULON & WHITE GOVERNANCE STRATEGIES $10,000
ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY ASSOCIATION FOR PROFESSIONALS IN INFECTION CONTROL AND EPIDEMIOLOGY undisclosed
PHARMATROPHIX, INC. FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) undisclosed
PGA TOUR, INC. FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC) undisclosed
RESPONSIVE GOV ACTION THE RABEN GROUP undisclosed
KERECIS INVARIANT LLC undisclosed
BINTI, INC. INVARIANT LLC undisclosed
VERTIV GROUP CORPORATION AKIN GUMP STRAUSS HAUER & FELD undisclosed
TERRA-GEN, LLC AKIN GUMP STRAUSS HAUER & FELD undisclosed
PHILIPS CONTINENTAL STRATEGY, LLC undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Kathy Castor, ranked by total contributions.

Health Professionals $80,000,000
Individuals: $80,000,000 PACs: $0
Retired $25,000,000
Individuals: $25,000,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us